Interventions for erythema nodosum leprosum. A Cochrane review.
Van Veen
Natasja H J
NH
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, The Netherlands.
Lockwood
Diana N J
DN
Van Brakel
Wim H
WH
Ramirez
J
J
Richardus
Jan Hendrik
JH
D001241:Aspirin / Q000627:therapeutic use; D002991:Clofazimine / Q000627:therapeutic use; D004893:Erythema Nodosum / Q000188:drug therapy*; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use*; D015440:Leprosy, Lepromatous / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013792:Thalidomide / Q000627:therapeutic use; D016896:Treatment Outcome
D007917:Leprostatic Agents; D013792:Thalidomide; D011239:Prednisolone; D002991:Clofazimine; D001241:Aspirin